[Molecular mechanism of action of sulfonylureas].
Ammon
H P
HP
Pharmazeutisches Institut, Universität Tübingen.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004285:Dogs; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects; D008954:Models, Biological; D010716:Phosphatidylinositols / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D051381:Rats; D011972:Receptor, Insulin / Q000187:drug effects; D013453:Sulfonylurea Compounds / Q000494:pharmacology* / Q000627:therapeutic use
D001786:Blood Glucose; D007328:Insulin; D010716:Phosphatidylinositols; D013453:Sulfonylurea Compounds; D011972:Receptor, Insulin; D000262:Adenylyl Cyclases; D011188:Potassium; D002118:Calcium
Molekularer Wirkungsmechanismus der Sulfonylharnstoffe.